These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 18319696)

  • 1. Evaluation of the left ventricular anatomy in hypertrophic cardiomyopathy: comparison between echocardiography and cardiac magnetic resonance imaging.
    Romano R; Losi MA; Migliore T; Contaldi C; Parrella LS; Caputi A; Betocchi S
    Minerva Cardioangiol; 2008 Apr; 56(2):181-7. PubMed ID: 18319696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spirito-Maron echocardiographic score: a marker for morphological and physiological assessment of patients with hypertrophic cardiomyopathy.
    Rangel I; Gonçalves A; de Sousa C; Correia AS; Pinho T; Madureira AJ; Martins E; Cardoso JS; Macedo F; Maciel MJ
    Echocardiography; 2014 Jul; 31(6):708-15. PubMed ID: 24460546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of Real Time 3D Echocardiography for the Assessment of Left Ventricular Mass in Patients with Hypertrophic Cardiomyopathy: Comparison with Cardiac Magnetic Resonance.
    Avegliano GP; Costabel JP; Asch FM; Sciancalepore A; Kuschnir P; Huguet M; Tobon-Gomez C; Frangi AF; Ronderos R
    Echocardiography; 2016 Mar; 33(3):431-6. PubMed ID: 26525462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy.
    Rickers C; Wilke NM; Jerosch-Herold M; Casey SA; Panse P; Panse N; Weil J; Zenovich AG; Maron BJ
    Circulation; 2005 Aug; 112(6):855-61. PubMed ID: 16087809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between maximal left ventricular wall thickness and left ventricular mass in patients with hypertrophic cardiomyopathy.
    Spiewak M; Chojnowska L; Małek LA; Miłosz B; Petryka J; Zabicka M; Kłopotowski M; Dabrowski M; Miśko J; Ruzyłło W
    Kardiol Pol; 2010 Jul; 68(7):763-8. PubMed ID: 20648432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance.
    Maron MS; Maron BJ; Harrigan C; Buros J; Gibson CM; Olivotto I; Biller L; Lesser JR; Udelson JE; Manning WJ; Appelbaum E
    J Am Coll Cardiol; 2009 Jul; 54(3):220-8. PubMed ID: 19589434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular wall thickness in patients with hypertrophic cardiomyopathy: a comparison between cardiac magnetic resonance imaging and echocardiography.
    Corona-Villalobos CP; Sorensen LL; Pozios I; Chu L; Eng J; Abraham MR; Abraham TP; Kamel IR; Zimmerman SL
    Int J Cardiovasc Imaging; 2016 Jun; 32(6):945-54. PubMed ID: 26896038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations.
    Germans T; Wilde AA; Dijkmans PA; Chai W; Kamp O; Pinto YM; van Rossum AC
    J Am Coll Cardiol; 2006 Dec; 48(12):2518-23. PubMed ID: 17174192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular mass and systolic function in children with chronic kidney disease-comparing echocardiography with cardiac magnetic resonance imaging.
    Arnold R; Schwendinger D; Jung S; Pohl M; Jung B; Geiger J; Gimpel C
    Pediatr Nephrol; 2016 Feb; 31(2):255-65. PubMed ID: 26342304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of left ventricular mass in hypertrophic cardiomyopathy by real-time three-dimensional echocardiography using single-beat capture image.
    Chang SA; Kim HK; Lee SC; Kim EY; Hahm SH; Kwon OM; Park SW; Choe YH; Oh JK
    J Am Soc Echocardiogr; 2013 Apr; 26(4):436-42. PubMed ID: 23363779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of Cardiac Magnetic Resonance Imaging to Measure Left Ventricular Wall Thickness for Determining Risk Scores for Sudden Cardiac Death in Patients With Hypertrophic Cardiomyopathy.
    Webb J; Villa A; Bekri I; Shome J; Teall T; Claridge S; Jackson T; Porter B; Ismail TF; Di Giovine G; Rinaldi CA; Carr-White G; Al-Fakih K; Razavi R; Chiribiri A
    Am J Cardiol; 2017 May; 119(9):1450-1455. PubMed ID: 28267963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy.
    Olivotto I; Maron MS; Autore C; Lesser JR; Rega L; Casolo G; De Santis M; Quarta G; Nistri S; Cecchi F; Salton CJ; Udelson JE; Manning WJ; Maron BJ
    J Am Coll Cardiol; 2008 Aug; 52(7):559-66. PubMed ID: 18687251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating biomarkers of hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy assessed by cardiac magnetic resonance.
    Gawor M; Śpiewak M; Kubik A; Wróbel A; Lutyńska A; Marczak M; Grzybowski J
    Biomarkers; 2018 Nov; 23(7):676-682. PubMed ID: 29737871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrepancies in Left Ventricular Mass Calculation Based on Echocardiography and Cardiovascular Magnetic Resonance Measurements in Patients with Left Ventricular Hypertrophy.
    Seo HY; Lee SP; Park JB; Lee JM; Park EA; Chang SA; Kim HK; Park SJ; Lee W; Kim YJ; Lee SC; Park SW; Sohn DW; Choe YH
    J Am Soc Echocardiogr; 2015 Oct; 28(10):1194-1203, e2. PubMed ID: 26194306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and imaging description of the Maron subtypes of hypertrophic cardiomyopathy.
    Reant P; Donal E; Schnell F; Reynaud A; Daudin M; Pillois X; Dijos M; Landelle M; Peyrou J; Cornolle C; Laurent F; Montaudon M; Roudaut R; Lafitte S
    Int J Cardiovasc Imaging; 2015 Jan; 31(1):47-55. PubMed ID: 25421460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of real time three-dimensional echocardiography in patients with hypertrophic cardiomyopathy: comparison with two-dimensional echocardiography and magnetic resonance imaging.
    Bicudo LS; Tsutsui JM; Shiozaki A; Rochitte CE; Arteaga E; Mady C; Ramires JA; Mathias W
    Echocardiography; 2008 Aug; 25(7):717-26. PubMed ID: 18445062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Maximal Wall Thickness in Hypertrophic Cardiomyopathy Differs Between Magnetic Resonance Imaging and Transthoracic Echocardiography.
    Bois JP; Geske JB; Foley TA; Ommen SR; Pellikka PA
    Am J Cardiol; 2017 Feb; 119(4):643-650. PubMed ID: 27956002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of left ventricular mass in hypertrophic cardiomyopathy using MRI: comparison with echocardiography.
    Allison JD; Flickinger FW; Wright JC; Falls DG; Prisant LM; VonDohlen TW; Frank MJ
    Magn Reson Imaging; 1993; 11(3):329-34. PubMed ID: 8505866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of three-dimensional echocardiographic findings to those of magnetic resonance imaging for determination of left ventricular mass in patients with ischemic and non-ischemic cardiomyopathy.
    Kusunose K; Kwon DH; Motoki H; Flamm SD; Marwick TH
    Am J Cardiol; 2013 Aug; 112(4):604-11. PubMed ID: 23768466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling.
    Rudolph A; Abdel-Aty H; Bohl S; Boyé P; Zagrosek A; Dietz R; Schulz-Menger J
    J Am Coll Cardiol; 2009 Jan; 53(3):284-91. PubMed ID: 19147047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.